🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 7 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/02/1997 | 44,13 | 44,61 | 43,77 | 44,61 | +1,63% | 1,89% | 4.826.250 |
| 06/02/1997 | 42,76 | 43,95 | 42,58 | 43,89 | +2,36% | 3,21% | 5.679.322 |
| 05/02/1997 | 44,01 | 44,07 | 42,46 | 42,88 | -1,91% | 3,66% | 4.227.213 |
| 04/02/1997 | 43,12 | 43,71 | 42,88 | 43,71 | +1,52% | 1,94% | 4.399.294 |
| 03/02/1997 | 43,36 | 43,54 | 42,88 | 43,06 | -0,41% | 1,51% | 4.274.163 |
| 31/01/1997 | 43,42 | 44,19 | 43,24 | 43,24 | +0,28% | 2,20% | 7.578.088 |
| 30/01/1997 | 42,58 | 43,18 | 42,34 | 43,12 | +2,41% | 1,96% | 6.203.112 |
| 29/01/1997 | 41,45 | 42,16 | 41,39 | 42,10 | +1,44% | 1,87% | 6.085.107 |
| 28/01/1997 | 41,15 | 41,87 | 40,91 | 41,51 | +2,96% | 2,32% | 6.289.048 |
| 27/01/1997 | 40,79 | 41,33 | 40,31 | 40,31 | -1,31% | 2,49% | 3.794.179 |
| 24/01/1997 | 41,21 | 41,81 | 40,79 | 40,85 | -0,72% | 2,46% | 6.127.027 |
| 23/01/1997 | 42,40 | 43,06 | 41,09 | 41,15 | -2,40% | 4,64% | 7.387.142 |
| 22/01/1997 | 41,51 | 42,28 | 41,39 | 42,16 | +2,17% | 2,16% | 5.070.434 |
| 21/01/1997 | 40,49 | 41,51 | 40,43 | 41,27 | +1,02% | 2,65% | 5.223.022 |
| 20/01/1997 | 40,85 | 41,15 | 40,37 | 40,85 | -0,44% | 1,90% | 5.259.493 |
| 17/01/1997 | 40,49 | 41,63 | 40,43 | 41,03 | +1,47% | 2,95% | 7.394.478 |
| 16/01/1997 | 39,84 | 40,73 | 39,66 | 40,43 | +1,80% | 2,69% | 6.318.392 |
| 15/01/1997 | 39,96 | 39,96 | 39,60 | 39,72 | -0,89% | 0,90% | 4.064.982 |
| 14/01/1997 | 39,78 | 40,37 | 39,72 | 40,08 | +1,20% | 1,65% | 5.602.608 |
| 13/01/1997 | 39,84 | 39,84 | 39,18 | 39,60 | -0,30% | 1,65% | 3.834.632 |
| 10/01/1997 | 39,00 | 39,72 | 38,82 | 39,72 | +0,76% | 2,29% | 4.122.413 |
| 09/01/1997 | 39,60 | 39,84 | 39,36 | 39,42 | +0,76% | 1,20% | 4.781.395 |
| 08/01/1997 | 39,72 | 39,90 | 39,00 | 39,12 | -1,20% | 2,25% | 4.884.728 |
| 07/01/1997 | 39,36 | 39,66 | 38,70 | 39,60 | +0,15% | 2,42% | 5.039.832 |
| 06/01/1997 | 39,42 | 40,08 | 39,18 | 39,54 | +0,30% | 2,27% | 7.512.693 |
| 03/01/1997 | 38,41 | 39,42 | 38,23 | 39,42 | +3,44% | 3,11% | 4.621.470 |
| 02/01/1997 | 37,99 | 38,11 | 37,21 | 38,11 | +0,31% | 2,35% | 5.675.758 |
| 31/12/1996 | 38,70 | 39,12 | 37,81 | 37,99 | -1,85% | 3,39% | 4.562.573 |
| 30/12/1996 | 38,88 | 39,18 | 38,47 | 38,70 | -0,61% | 1,84% | 4.517.090 |
| 27/12/1996 | 39,12 | 39,18 | 38,88 | 38,94 | -0,15% | 0,76% | 2.171.456 |